Scandinavian ChemoTech
3.89 SEK
-11.19 %
Less than 1K followers
CMOTEC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-11.19 %
-22.51 %
-18.79 %
-27.96 %
+76.82 %
+277.67 %
-36.74 %
-66.40 %
-89.67 %
Scandinavian ChemoTech is a Swedish company that develops and markets medical technology based on electrochemotherapy for the treatment of cancer. The company offers systems and solutions to clinics in oncology and veterinary medicine and has operations in international markets, including India and Southeast Asia. The company was founded in 2015 and is headquartered in Lund, Sweden.
Read moreMarket cap
99.02M SEK
Turnover
63.36K SEK
Revenue
6.57M
EBIT %
-194.82 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
17.2
2026
Annual report '25
28.4
2026
Interim report Q1'26
5.5
2026
General meeting '26
All
Press releases
ShowingAll content types
(RETRANS) ChemoTech's Animal Care Announces First U.S. Order from Leading Equine Clinic in Kentucky
ChemoTech's Animal Care Announces First U.S. Order from Leading Equine Clinic in Kentucky
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools